Legal Headlines

The disease known as bronchiectasis is characterized by a localized dilation on part of the bronchial tree – which is irreversible. The disease is placed in the category of obstructive lung diseases, along with cystic fibrosis and bronchitis. In this case, the bronchi that are involved are inflamed, dilated and will easily collapse – resulting in an obstructed airflow with secretion clearance impaired. This condition is associated with a wide range of causes and disorders, but it usually is the result of bacterial infections such as those caused by the staphylococcus bacteria (most commonly known as a staph infection).

This condition was first diagnosed in 1819 by Rene Laënnec, the inventor of the stethoscope. His invention was used in the initial diagnosis. Sir William Osler researched the disease in greater detail during the late 1800s. Ironically, it is suspected that Osler died from complications from bronchiectasis that was undiagnosed.

High resolution CT scans along with a review of the patient’s clinical history are used in the diagnosis of this condition. Significant patterns in the CT scan that can lead to a positive diagnosis include “tree-in-bud” abnormalities and cysts that have definable borders. Bronchiectasis can also be diagnosed through a clinical history of frequent respiratory infections along with sputum cultures and blood work.

The treatment of this disease involves controlling the subsequent infections, resolving airway obstructions, controlling bronchial secretions and the preventing of further complications. To this end, the extensive use of antibiotics will be indicated to prevent infections. Accumulated fluid will be eliminated with chest-specific physiotherapy and postural drainage. Surgery can also be used to treat bronchiectasis through the removal of obstructions that would lead to a progression of the disease.

Sputum production and airway constriction can be reduced through the use of inhaled steroid therapy. This therapy will also prevent the progression of the disease. The use of inhalers can also reduce inflammation and by clearing the airways, also reduce the appearance of infections.

Therapies that are used in combination, such as corticosteroid inhalers and long acting bronchodilators may also reduce inflammation, reduce sputum production and help clear the airways. These inhalers can come in different medicinal forms that will be “balanced” by the physician.

Please note that this article is for informational purposes only and is not intended as legal advice.

More information on Social Security benefits for bronchiectasis patients may be obtained by visiting the website of Attorney Gerard Lynch, representing Social Security cases in Corpus Christi and throughout the state of Texas.